Patents by Inventor Stephen W. Scherer

Stephen W. Scherer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for Autism Spectrum Disorders
    Publication number: 20220136055
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Application
    Filed: January 21, 2022
    Publication date: May 5, 2022
    Inventors: Stephen W Scherer, John B Vincent
  • Biomarkers for autism spectrum disorders
    Patent number: 11254984
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: February 22, 2022
    Assignee: The Hospital for Sick Children
    Inventors: Stephen W Scherer, John B Vincent
  • Biomarkers for Autism Spectrum Disorders
    Publication number: 20200157628
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Application
    Filed: November 25, 2019
    Publication date: May 21, 2020
    Inventors: Stephen W Scherer, John B Vincent
  • Biomarkers for autism spectrum disorders
    Patent number: 10526653
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: January 7, 2020
    Assignees: The Centre for Addiction and Mental Health, The Hospital for Sick Children
    Inventors: Stephen W Scherer, John B Vincent
  • LaFORA'S DISEASE GENE
    Publication number: 20160215347
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: April 7, 2016
    Publication date: July 28, 2016
    Applicants: The Hospital for Sick Children, McGill University, U.S. Government Department of Veterans Affairs, The Regents of the University of California
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleau
  • LAFORA'S DISEASE GENE
    Publication number: 20160177393
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 23, 2016
    Applicant: THE HOSPITAL FOR SICK CHILDREN
    Inventors: Stephen W. Scherer, Berge A. Minassian
  • Lafora's disease gene
    Patent number: 9334539
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: May 10, 2016
    Assignees: The Hospital for Sick Children, McGill University, The Regents of the University of California, U.S. Department of Veterans Affairs
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleau
  • Lafora's disease gene
    Patent number: 9222135
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: December 29, 2015
    Assignee: The Hospital for Sick Children
    Inventors: Stephen W. Scherer, Berge A. Minassian
  • BIOMARKERS FOR AUTISM SPECTRUM DISORDERS
    Publication number: 20150322518
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Application
    Filed: February 24, 2015
    Publication date: November 12, 2015
    Inventors: Stephen W. Scherer, John B. Vincent
  • LAFORA'S DISEASE GENE
    Publication number: 20140072970
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Application
    Filed: May 24, 2013
    Publication date: March 13, 2014
    Applicant: The Hospital for Sick Children
    Inventors: Stephen W. Scherer, Berge A. Minassian
  • LaFORA'S DISEASE GENE
    Publication number: 20140057971
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: June 24, 2013
    Publication date: February 27, 2014
    Applicants: The Hospital for Sick Children, The Regents of the University of California, U.S. Government Department of Veterans Affairs, McGill University
    Inventors: Stephen W. SCHERER, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleau
  • Lafora's disease gene
    Patent number: 8486624
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 16, 2013
    Assignees: The Hospital for Sick Children, McGill University, The Regents of the University of California, The United States of America, as represented by the Department of Veterans Affairs
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Patent number: 8450060
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: May 28, 2013
    Assignee: The Hospital For Sick Children
    Inventors: Stephen W. Scherer, Berge A. Minassian
  • Biomarkers for Autism Spectrum Disorders
    Publication number: 20120100995
    Abstract: Methods of determining the risk of ASD or ID in an individual are provided which comprise identifying the presence of one or more specific genomic mutations in, upstream of, or comprising the PTCHD1 gene. Additionally provided are methods of determining the risk of ASD or ID in an individual comprising analyzing genomic mutations in PTCHD1AS1 and/or PTCHD1AS2 and/or PTCHD1AS3.
    Type: Application
    Filed: September 13, 2011
    Publication date: April 26, 2012
    Inventors: Stephen W. Scherer, John B. Vincent
  • LAFORA'S DISEASE GENE
    Publication number: 20120070826
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Application
    Filed: January 14, 2011
    Publication date: March 22, 2012
    Inventors: Stephen W. Scherer, Berge A. Minassian
  • Lafora's disease gene
    Patent number: 7871768
    Abstract: A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: January 18, 2011
    Assignee: The Hospital for Sick Children
    Inventors: Stephen W. Scherer, Berge A Minassian
  • BIOMARKERS FOR AUTISM SPECTRUM DISORDERS
    Publication number: 20100248235
    Abstract: Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
    Type: Application
    Filed: October 3, 2008
    Publication date: September 30, 2010
    Inventors: Stephen W. Scherer, John B. Vincent
  • Lafora's disease gene
    Publication number: 20100009346
    Abstract: A novel gene (EPMZA) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EMP2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: October 31, 2007
    Publication date: January 14, 2010
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Patent number: 7550571
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Grant
    Filed: July 8, 2004
    Date of Patent: June 23, 2009
    Assignees: McGrill University, The Hospital for Sick Children, The Regents of the University of California
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Publication number: 20040241740
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: July 8, 2004
    Publication date: December 2, 2004
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu